D-0489-2025 Class II Ongoing

Recalled by Pfizer Inc. — New York, NY

Recall Details

Product Type
Drugs
Report Date
July 2, 2025
Initiation Date
May 28, 2025
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
98,410 vials

Product Description

DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, For Intravenous Use Only, Made in Italy, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC Carton: 0409-2344-02; NDC Vial: 0409-2344-62

Reason for Recall

Discoloration; discolored solution from cracked vials

Distribution Pattern

Nationwide in the USA

Code Information

Lot KA5023, exp 02/28/2026